Second Look at Drug Patents Act of 2020

United States116th CongressS-4253Senate
Updated: Jul 21, 2020

Summary

Second Look at Drug Patents Act of 2020 This bill imposes additional patent reporting requirements on the manufacturers of certain drugs approved by the Federal Drug Administration.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Senate

All available records shown.